The CRISPR/Cas9 technology was used to create a mutant SH-SY5Y cell line in which Aβ production was significantly increased (Fang et al., 2006), suggesting that PSEN1 mutations have a role in AD pathophysiology. The gene discussed is PSEN1; the disease is Alzheimer disease.